The Lead Episode 36: A Discussion of One-Year Outcomes Following Stereotactic Body Radiotherapy for Refractory Ventricular Tachycardia

Discussion Topic: One-Year Outcomes Following Stereotactic Body Radiotherapy for Refractory Ventricular Tachycardia

William H. Sauer, MD, FHRS, CCDS, of Brigham and Women’s Hospital is joined by guests Esseim Sharma, MD, of University Hospitals Cleveland, and Paul C Zei, MD, PhD, FHRS, of Brigham and Women’s Hospital to discuss One-Year Outcomes Following Stereotactic Body Radiotherapy for Refractory Ventricular Tachycardia. Cardiac stereotactic body radiotherapy (SBRT) has emerged as a promising noninvasive treatment for refractory ventricular tachycardia (VT). The objective is to describe the safety and effectiveness of SBRT for VT in refractory to extensive ablation. For a select group of high-risk patients with VT refractory to standard therapy, SBRT is associated with a reduction of in VT and appropriate ICD therapies.

Host: William H. Sauer, MD, FHRS, CCDS
Guests: Esseim Sharma, MD and Paul C. Zei, MD, PhD, FHRS

Speaker and Article Information: Download
Visual Aid Provided by Host: Download

• Listen on HRS365
• Listen on Apple Podcasts
• Listen on Spotify